Epigenomics AG (FRA:ECX)
1.150
-0.050 (-4.17%)
Aug 12, 2026, 8:01 AM CET
30.68% (1Y)
| Market Cap | 1.05M +34.8% |
| Revenue (ttm) | 24.00K |
| Net Income | -314.00K |
| EPS | -0.36 |
| Shares Out | 876.98K |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 342 |
| Open | 1.150 |
| Previous Close | 1.200 |
| Day's Range | 1.150 - 1.150 |
| 52-Week Range | 0.840 - 1.590 |
| Beta | 0.87 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 6, 2026 |